Tirbanibulin

Tirbanibulin(KX2-391,KX 01), the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.

• Supplier: Selleck Chemicals
• Product #: S2700
• Sku #: S2700-10mM/1mL